X @Bloomberg
Company Performance - Eli Lilly was approaching a $1 trillion company valuation [1] - The company is currently facing missed targets [1] Market Dynamics & Risks - The company is facing tariff threats [1] - Investor doubts are emerging regarding the company [1]